Obesity Linked to Ovarian Cancer

Excess estrogen may contribute to malignancy, study suggests. Obese postmenopausal women who have never used hormone replacement therapy may face an increased risk of ovarian cancer, compared to normal-weight women, a new study suggests.

Interestingly, obese women who have used hormone replacement therapy (HRT) for symptoms of menopause may not face increased risk for this type of malignancy.

The study findings are published in the Feb.
More ...

DON'T HAVE Rx COVERAGE?
Click Here to print out your FREE OPTIMIZERx Card and instantly begin savings on your next prescriptions!
tell-a-friend about prescription savings